03843nam a22005895i 45000010014000000030009000140050017000230060019000400070015000590080041000740100015001150200018001300240031001480350021001790400033002000410008002330440015002410500010002560500022002660720023002880820024003111000076003352450086004112640047004972640011005443000031005553360026005863370026006123380036006383470024006744900065006985050517007635060104012805201115013845380049024995460016025485880112025646500046026766500028027226500030027506500042027806500044028226500054028666500063029206500065029838560049030488560080030979120016031779120017031939120019032109120024032299781478022282DE-B159720220329044247.0m|||||o||d||||||||cr || ||||||||220329t20222022ncu    fo  d z      eng d  a2021025277  a97814780222827 a10.1515/97814780222822doi  a(DE-B1597)624492  aDE-B1597bengcDE-B1597erda0 aeng  ancucUS-NC00aRC537 4aRC537b.E257 2022 7aSOC0020102bisacsh04a338.4/7615109542231 aEcks, Stefan, eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aLiving Worth :bValue and Values in Global Pharmaceutical Markets /cStefan Ecks. 1aDurham : bDuke University Press, c[2022] 4c©2022  a1 online resource (285 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aCritical Global Health: Evidence, Efficacy, Ethnography : 4700tFrontmatter -- tContents -- tAcknowledgments -- tIntroduction -- tONE Embodied Value Theory -- tTWO Relative Value -- tTHREE Never Enough -- tFOUR Making a Difference -- tFIVE Pharmaceutical Citizenship, Marketing, and the Global Monoculture of Health -- tSIX What Drugs Do in Different Spaces -- tSEVEN Acting through Other (Prescribing) Habits -- tEIGHT Culture, Context, and Consensus -- tNINE Generic -- tTEN Same Ills, Same Pills -- tELEVEN Failed Biocommensurations -- tReferences -- tIndex0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aIn Living Worth Stefan Ecks draws on ethnographic research on depression and antidepressant usage in India to develop a new theory of value. Framing depressive disorder as a problem of value, Ecks traces the myriad ways antidepressants come to have value, from their ability to help make one’s life worth living to the wealth they generate in the multibillion-dollar global pharmaceutical market. Through case studies that include analyses of the different valuation of generic and brand-name drugs, the origins of rising worldwide depression rates, and the marketing, prescription, and circulation of antidepressants, Ecks theorizes value as a process of biocommensuration. Biocommensurations—transactions that aim or claim to make life better—are those forms of social, medical, and corporate actions that allow value to be measured, exchanged, substituted, and redistributed. Ecks’s theory expands value beyond both a Marxist labor theory of value and a free market subjective theory, thereby offering new insights into how the value of lives and things become entangled under neoliberal capitalism.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 29. Mrz 2022) 0aAntidepressantsxEconomic aspectszIndia. 0aAntidepressantszIndia. 0aDepressed personszIndia. 0aDepression, MentalxTreatmentzIndia. 0aMental healthxEconomic aspectszIndia. 0aPharmaceutical industryxEconomic aspectszIndia. 0aPharmaceutical industryxMoral and ethical aspectszIndia. 7aSOCIAL SCIENCE / Anthropology / Cultural & Social.2bisacsh40uhttps://www.degruyter.com/isbn/9781478022282423Coveruhttps://www.degruyter.com/document/cover/isbn/9781478022282/original  aEBA_DUK_ALL  aEBA_DUK_EALL  aEBA_DUK_SSHALL  aGBV-deGruyter-alles